|
|
New! Section 1 Accredited E-Learning Program: Challenges of Lowering LDL-C: The Role of PCSK-9 |
 |
 |
 |
|
This accredited educational program will describe current gaps in treatment to reduce LDL-C levels to suggested targets in patients at risk of cardiovascular events. Emerging therapies to reduce LDL-C will be reviewed, with a focus on the putative role pf PCSK9 in regulating LDL-C plasma levels.
At the completion of this program, participants will be able to:
>> Remain vigilant in terms of the need to reach suggested plasma LDL-C targets in all partients
>> Identify the investigational agents in clinical trials to lower plasma LDL-C
>> Explain the putative role of PCS9 as a regulator of plasma LDL-C and early efforts investigating it's inhibition
Challenges of Lowering LDL-C: The Role of PCSK-9
Section 1 credits: 1
Expiry Date: April 16, 2014
|
|
|
CCS Dyslipidemia Guidelines Webinar recording now available |
|
|
|
|
Did you miss our Dyslipidemia or CRT Guideline Webinar?
We know space was limited so we recorded the webinars and posted them on our website for on demand viewing. You can view the slides and hear the audio along with participant questions and our expert panel’s responses. Webinars are a convenient way to learn about the newest guideline updates and recommendations.
You will be prompted to enter your email address and then your first and last name to download/stream the file.
 Webinar Recording Available
|
|
|
Online orders for pocket guides no longer available |
|
|
|
|
Please note, CCS pocket guides are no longer available for order online. All orders received prior to March 25th will be fulfilled.
Please see our online versions or check out our smartphone apps.
|
|
